🇫🇷 PhD Stat | Med Prof. in Public Health | 🆔 Consultant | AEditor @IDSAinfo journals | Lampshade❤️| Chess♟️| Poker♦️

Bayeux, France
Joined August 2015
Thrilled by my new role as #Methodology Associate Editor for @IDSAInfo journals! Excited to collaborate with @PaulSaxMD, @CIDJournal EiC, Cynthia L. Sears, @JIDJournal EiC and Roger J. Bedimo @OFIDJournal Grateful for this opportunity! #Research #EditorialTeam #IDTwitter
6
2
23
4,520
#IDWeek2026 #HIV #Adherence Join me at Poster 1054 today (12:15–1:30 PM) to discuss the gap between RWD adherence and the vital need to study ART in populations underrepresented in RCTs 🇫🇷 speaking allowed 😉
2
2
5
853
Jean-Jacques Parienti, MD 🇫🇷 retweeted
As noted in the @BostonGlobe, COVID is back! And it's not what it used to be! To ID doctors, neither statement is particularly surprising. But why is this happening? A brief explainer, with a few recycled PowerPoint slides. Free-to-read link in replies. @akuchment
13
23
3
92
42,177
Jean-Jacques Parienti, MD 🇫🇷 retweeted
This alternate week activity somehow is one of the most enjoyable activities of my adult life. Who knew? Free link in replies @JjParienti
3
3
12
2,507
#HIV #Rio In double-blind ISLEND-1, the rates of adverse events were: 13% for ISL/LEN 13% for B/F/TAF 🟰 In open-label ISLEND-2, the rates of adverse events were: 18% for ISL/LEN <1% for SOC ✖️ A nice illustration of attribution bias in switch RCTs 😉 aidsmap.com/news/jul-2026/on…
1
4
743
Jean-Jacques Parienti, MD 🇫🇷 retweeted
Understanding the Clone–Censor–Weight Method in Observational Studies of Antibiotic Duration ✅ Just Accepted 🔗 bit.ly/4bKJHle
1
3
1
11
1,420
France - Spain ⚽️ is final before final Both can win Hope the best creative team will win No penalty 🙏
1
1
2
182
Replying to @jesusrbano
Congratulations and Ty for sharing free link I do not understand why the upper bound of the btw group difference is infinite. Given your one-sided 5% hypothesis, this might be a 90% CI with 2 bounds. Otherwise it is not an interval?
1
1
2,583
Check out this thread on Vera Health. Interesting answer. Your thoughts? verahealth.ai/m/search/2f193…
116
New @CIDJournal supplement co-authored by @davidantibiotic and team ! Fascinating and cutting-edge réflexion on AMR and Clinical research
The latest CID supplement issue highlights the clinical and research framework needed to combat antimicrobial resistance and accelerate progress in antibiotic development. ↪️ bit.ly/4xgx8r2
1
2
373
Happy to share I reached > 50 stat peer-RW for TLID 🤩 Lucky to play even a small part in upholding rigorous standards bc robust science,😉 when preferred to ideology 😵‍💫 has the power to protect the health of countless ppl in a world full of hesitancy and misinformation
1
1
2
234
#Methodology #Cooking #SundayVibes Saint-Julien grand cru de Bordeaux dans mon #BoeufBourguignon ? Hé oui… comme dans les meilleures #metaanalyses : good in, good out 😏🍷🔥
148